Human CCL3/MIP-1 alpha Luminex Performance Assay

Name Human CCL3/MIP-1 alpha Luminex Performance Assay
Supplier R&D Systems
Catalog LUH270
Assay Type Bead-based multiplex assay for the Luminex® platform
Format 96-well microplate and antibody-coated beads*
Species Reactivities Human
Gene CCL3
Supplier Page Shop

Product References

Elevated cerebral spinal fluid cytokine levels in boys with cerebral - Elevated cerebral spinal fluid cytokine levels in boys with cerebral

Lund TC, Stadem PS, Panoskaltsis-Mortari A, Raymond G, Miller WP, Tolar J, Orchard PJ. PLoS One. 2012;7(2):e32218.

Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. - Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.

Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M, Kuwano M, Kamura S, Iida K, Okada Y, Koga M, Iwamoto Y. Am J Pathol. 2011 Sep;179(3):1157-70.

Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal - Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal

Moyes DL, Murciano C, Runglall M, Islam A, Thavaraj S, Naglik JR. PLoS One. 2011;6(11):e26580.

Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi - Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi

Cox-Singh J, Singh B, Daneshvar C, Planche T, Parker-Williams J, Krishna S. PLoS One. 2011;6(6):e20541.

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance - The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance

Durig J, Duhrsen U, Klein-Hitpass L, Worm J, Hansen JB, Orum H, Wissenbach M. Leukemia. 2011 Apr;25(4):638-47.

Potential biomarkers of osteonecrosis in Gaucher disease. - Potential biomarkers of osteonecrosis in Gaucher disease.

Pavlova EV, Deegan PB, Tindall J, McFarlane I, Mehta A, Hughes D, Wraith JE, Cox TM. Blood Cells Mol Dis. 2011 Jan 15;46(1):27-33.

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its - Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its

O'Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, Mirsalis J, d'Andrea AL, Hume SD, Bratcher B, Saucedo CJ, McMahon JB, Pogue GP, Palmer KE. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6099-104. doi:

Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the - Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the

Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP. J Immunol. 2009 May 15;182(10):6460-9.

Critical and differential roles of NKp46- and NKp30-activating receptors - Critical and differential roles of NKp46- and NKp30-activating receptors

El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O, Clouet-Delannoy M, Lombardelli L, Jabrane-Ferrat N, Rukavina D, Bensussan A, Piccinni MP, Le Bouteiller P, Tabiasco J. J Immunol. 2008 Sep 1;181(5):3009-17.

Relation of circulating concentrations of chemokine receptor CCR5 ligands to - Relation of circulating concentrations of chemokine receptor CCR5 ligands to

Pfleger C, Kaas A, Hansen L, Alizadeh B, Hougaard P, Holl R, Kolb H, Roep BO, Mortensen HB, Schloot NC. Clin Immunol. 2008 Jul;128(1):57-65.